Chargement en cours...
Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab
Novel emerging therapies have changed paradigms in metastatic colorectal cancer. The advantages of molecular targeted treatments, either the anti-angiogenic or the anti-epidermal growth factor receptor drugs, reside in the fact that while their specificity for the cancer cell is higher, their toxici...
Enregistré dans:
| Publié dans: | Clujul Med |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Iuliu Hatieganu University of Medicine and Pharmacy
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683825/ https://ncbi.nlm.nih.gov/pubmed/29151784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15386/cjmed-745 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|